MYC and cancer: In a recent study published in Nature, Zhang et al. explored the nutrient competition between cancer cells as well as their competition with macrophages during cancer development.1 Their data demonstrated that tumor-associated macrophage (TAM) can be dietarily or genetically reprogrammed to win in the competition with MYC-overexpressing cancer cells, providing new insights into our understanding of tumor development and immunotherapy.